+499.5%
MRNA vs EQX
+42.9%
+456.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EQX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.4% | +0.1% | -0.5% |
| 7D | +5.5% | -1.4% | +6.9% | +5.8% |
| 30D | +158.7% | +24.4% | +134.4% | +139.6% |
| 3M | +182.1% | +11.6% | +170.5% | +166.0% |
| 6M | +151.8% | -25.0% | +176.8% | +157.7% |
| YTD | +393.6% | -8.4% | +401.9% | +378.2% |
| 1Y | +499.5% | +43.4% | +456.1% | +431.1% |
| All | +499.5% | +42.9% | +456.5% | +431.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EQX.
Daily Out/Under-Performance
Portfolio return minus EQX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EQX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling